CA Patent

CA2115990A1 — Angiotensin ii receptor blocking imidazolinone derivatives

Assigned to EIDP Inc · Expires 1993-03-04 · 33y expired

What this patent protects

Novel imidazolinone derivatives of formula (I), which are useful as angiotensin II antagonists, are disclosed.

USPTO Abstract

Novel imidazolinone derivatives of formula (I), which are useful as angiotensin II antagonists, are disclosed.

Drugs covered by this patent

Patent Metadata

Patent number
CA2115990A1
Jurisdiction
CA
Classification
—
Expires
1993-03-04
Drug substance claim
No
Drug product claim
No
Assignee
EIDP Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.